fda tirzepatide shortage update off the list What Is Tirzepatide Used for? Approved and Potential Uses FDA Response to Shortage Notification

Dosing Comparison# Retatrutide Dosing# Based on Phase 2 trial data: Route : Once-weekly subcutaneous injection Dose range studied : 0.5 mg to 12 mg weekly Optimal dose : 12 mg weekly showed maximum efficacy in Phase 2 Titration : Gradual dose escalation over several weeks to manage GI tolerability Tirzepatide Dosing# Established FDA-approved dosing: Route : Once-weekly subcutaneous injection Starting dose : 2.5 mg weekly for 4 weeks Maintenance range : 5 mg, 10 mg, or 15 mg weekly Titration : 2.5 mg increments every 4 weeks to target dose Available formulations : Prefilled pens (Mounjaro/Zepbound) Tirzepatide's established titration protocol and prefilled pen delivery system offer practical advantages in clinical use

By 6 months tirzepatide, the average time to work shows full results

Sources: U.S

The compounding difference Compounded tirzepatide and compounded semaglutide are prepared by compounding pharmacies and may contain different excipients (inactive ingredients), different concentrations, and different purity profiles than FDA-approved formulations

Here is where the problem starts

Customers who have a personalized dosing regimen will be able to continue without any change, the company added